OPKO Health, Inc. (NASDAQ: OPK), announces that it has completed its previously announced acquisition of Transition Therapeutics, Inc. (NASDAQ: TTHI, TSX: TTH), by way of a plan of...
OPKO Health, Inc. (Nasdaq: OPK), announces that at a Special Shareholder Meeting held on August 25, 2016 shareholders of Transition Therapeutics, Inc. (NASDAQ:TTHI, TSX: TTH) holding...
Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc. PR Newswire TORONTO, Aug. 25, 2016...
All-stock transaction valued at approximately US$60 million, or US$1.55 per Transition Therapeutics share OPKO to gain potential first-to-market GLP-1/Glucagon dual agonist for type 2...
Transition Therapeutics Receives Notification From NASDAQ Canada NewsWire TORONTO, June 3, 2016 TORONTO, June 3, 2016 /CNW/ - Transition Therapeutics Inc. ("Transition" or the...
Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results PR Newswire TORONTO, May 11, 2016 TORONTO, May 11, 2016 /PRNewswire/ - Transition Therapeutics Inc...
Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST PR Newswire TORONTO, May 9, 2016 TORONTO, May 9, 2016...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.